Hwei‐Ming Peng

1.5k citations
37 papers · 1.2k indexed · h-index 20

Hwei‐Ming Peng

35 papers receiving 1.2k citations

Peers

Hwei‐Ming Peng
Comparison fields: 5 of 96
  • Pharmacology 291
  • Aging 31
  • Cell Biology 182
  • Molecular Biology 759
  • Endocrinology, Diabetes and Metabolism 165
Replace Benjamin Le Calvé with:
Benjamin Le Calvé Belgium
Barbara Becattini Sweden
Paul M. Epstein United States
Barry G. Shearer United States
Tadashi Ogishima Japan
Clint D.J. Tavares United States
Barry D. Gehm United States
Ayako Harada Japan
Shuhei Ishikura Japan
Gareth Waldron United Kingdom
Hwei‐Ming Peng relative to Benjamin Le Calvé Belgium Benjamin Le Calvé's profile →
Citations per field
00.5×7.5×
Benjamin Le Calvé · 1×
Citations per year

Countries citing papers authored by Hwei‐Ming Peng

Since Specialization
Citations

This map shows the geographic impact of Hwei‐Ming Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hwei‐Ming Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hwei‐Ming Peng more than expected).

Fields of papers citing papers by Hwei‐Ming Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hwei‐Ming Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hwei‐Ming Peng. The network helps show where Hwei‐Ming Peng may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Hwei‐Ming Peng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hwei‐Ming Peng Line = papers co-authored together Hwei‐Ming Peng links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 202315
2 20230
3 201810
4 201525
5 201434
6 201427
7 201311
8 201210
9 2012152
10 201135
11 201077
12 201010
13 200672
14 200415
15 200464
16 200246
17 200029
18 199861
19 199220
20 19928

About Hwei‐Ming Peng

Hwei‐Ming Peng is a scholar working on Pharmacology, Endocrinology, Diabetes and Metabolism and Aging, having authored 37 papers that have together received 1.2k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (18 papers), Heat shock proteins research (12 papers), Hormonal Regulation and Hypertension (8 papers), Mitochondrial Function and Pathology (7 papers), Drug Transport and Resistance Mechanisms (6 papers), Hormonal and reproductive studies (6 papers), Estrogen and related hormone effects (5 papers) and Coenzyme Q10 studies and effects (4 papers). The work is most often cited by research in Pharmacology (291 citations), Aging (31 citations) and Cell Biology (182 citations). Hwei‐Ming Peng has collaborated with scholars based in United States, Australia and Canada. Frequent co-authors include Yoshihiro Morishima, William B. Pratt, Yoichi Osawa, Minor J. Coon, Richard J. Auchus, Andrew P. Lieberman, Jason E. Gestwicki, Xinxin Ding, Kostas P. Vatsis and Adrienne M. Wang. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and The Journal of Clinical Endocrinology & Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026